Senate Holds Hearing on 340B Drug Pricing Program

Conclusion Given the widespread support for the 340B program, it is likely that it is here to stay. What remains to be seen, however, is whether Congress will work to reign in the out-of-control side of it and modify it back on a sustainable path like was initially intended.       Related StoriesHouse of Representatives Holds Two-Day Hearing on OpioidsHigher Outpatient Drug Spending At 340B Hospitals, According to New AnalysisHouse Subcommittee on Health Holds Hearing on MACRA 
Source: Policy and Medicine - Category: American Health Authors: Source Type: blogs